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This differential degradation allows cells
to adaptmitochondrial proteolytic activity
and influence aspects of mitochondrial
biology such as mitochondrial
morphology in response to distinct
cellular insults.
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The mitochondrial inner membrane proteases
YME1L and OMA1 are critical regulators of essential
mitochondrial functions, including inner membrane
proteostasis maintenance and mitochondrial dy-
namics. Here, we show that YME1L and OMA1 are
reciprocally degraded in response to distinct types
of cellular stress. OMA1 is degraded through a
YME1L-dependent mechanism in response to toxic
insults that depolarize the mitochondrial membrane.
Alternatively, insults that depolarize mitochondria
and deplete cellular ATP stabilize active OMA1 and
promote YME1L degradation. We show that the dif-
ferential degradation of YME1L andOMA1 alters their
proteolytic processing of the dynamin-like GTPase
OPA1, a critical regulator of mitochondrial inner
membrane morphology, which influences the re-
covery of tubular mitochondria following mem-
brane-depolarization-induced fragmentation. Our
results reveal the differential stress-induced degra-
dation of YME1L and OMA1 as a mechanism for
sensitively adapting mitochondrial inner membrane
protease activity and function in response to distinct
types of cellular insults.INTRODUCTION
Mitochondrial inner membrane proteases regulate essential
functions including electron transport chain activity, mito-
chondrial inner membrane proteostasis maintenance, and
mitochondrial dynamics (Anand et al., 2013; Quiro´s et al.,
2015). Imbalances in the activity of these proteases can lead
to pathologic mitochondrial dysfunction and are implicated
in the onset and pathology of many diseases (Rugarli and
Langer, 2012). As such, mitochondrial inner membrane prote-
ases must be regulated to adapt mitochondrial proteolytic
activity to specific cellular demands and environmental
challenges.
Two mitochondrial proteases that regulate proteostasis in the
inner membrane and intermembrane space (IMS) are the ATP-Ceindependent protease OMA1 and the ATP-dependent AAA+
protease YME1L. These proteases assemble as homo-
oligomers in the inner membrane with their active sites oriented
toward the IMS (Baker et al., 2014; Stiburek et al., 2012).
YME1L is constitutively active. Conversely, OMA1 is main-
tained in a quiescent state in the absence of stress and is acti-
vated in response to cellular insults such as mitochondrial
membrane depolarization (Baker et al., 2014; Zhang et al.,
2014). YME1L and OMA1 have many independent functions
(Bohovych et al., 2015; Desmurs et al., 2015; Jiang et al.,
2014; Li et al., 2015; Rainbolt et al., 2013; Stiburek et al.,
2012). However, these proteases coordinate to regulate mito-
chondrial morphology through their differential processing of
the dynamin-like GTPase OPA1 (Anand et al., 2014). YME1L-
dependent OPA1 processing promotes tubular mitochondrial
morphology, while OMA1-dependent OPA1 processing in-
duces mitochondrial fragmentation (Anand et al., 2014; Mishra
et al., 2014; Quiro´s et al., 2012). Mitochondrial morphology in-
fluences many aspects of mitochondrial biology including
electron transport chain (ETC) activity, apoptotic sensitivity,
and mitophagy (Chan, 2012). Thus, the regulation of mitochon-
drial morphology afforded by differential YME1L- and OMA1-
dependent OPA1 processing is a key determinant in dictating
mitochondrial function.
YME1L and OMA1 have both been shown to be stress-sen-
sitive mitochondrial proteases (Baker et al., 2014; Rainbolt
et al., 2015; Zhang et al., 2014). This suggests that the activity
of these proteases could be regulated to adapt mitochondrial
function to specific types of cellular stress. Here, we show
that YME1L and OMA1 are reciprocally degraded in response
to distinct types of toxic insults. OMA1 is degraded through a
YME1L-dependent mechanism following insults that depo-
larize mitochondria. Alternatively, YME1L is degraded in
response to insults that depolarize mitochondria and deplete
cellular ATP through a mechanism involving OMA1 (Rainbolt
et al., 2015). Furthermore, we show that the differential degra-
dation of YME1L and OMA1 alters their proteolytic processing
of OPA1 and influences the recovery of mitochondrial
morphology following stress-induced fragmentation. Our re-
sults reveal that differential stress-induced YME1L and
OMA1 degradation is a mechanism for cells to sensitively
adapt mitochondrial inner membrane proteolytic activity and
influence aspects of mitochondrial biology in response to
distinct types of stress.ll Reports 14, 2041–2049, March 8, 2016 ª2016 The Authors 2041
Figure 1. Membrane-Depolarization-Indu-
ced OMA1 Degradation Requires ATP
(A) Immunoblot of mitochondria isolated from
SHSY5Y cells incubated with or without ATP
(5 mM) at 37C for 6 hr, as indicated.
(B) Representative immunoblot of lysates from
SHSY5Y cells treated with CCCP (25 mM) alone or
with 2-deoxy-D-glucose (2-DG; 10 mM) for the
indicated time.
(C) Quantification of normalized OMA1 protein
levels from immunoblots as depicted in Figure 1B.
Error bars showSEM for n = 3. *p < 0.05, **p < 0.01,
and ***p < 0.001
(D) Immunoblot of lysates prepared from SHSY5Y
cells cultured in galactose-supplemented media
treated with oligomycin A (OA; 5 nM) and/or CCCP
(50 mM) for 6 hr.
(E) Quantification of normalized OMA1 and YME1L
protein levels from immunoblots as shown in Fig-
ure 1D. Error bars show SEM for n = 3. *p < 0.05.
(F) Quantification of normalized OMA1 and YME1L
protein levels from immunoblots as shown in Fig-
ure S1G. Error bars show SEM for n = 4. *p < 0.05.
(G) Illustration showing the differential degradation
of YME1L and OMA1 induced by membrane de-
polarization in the presence or absence of ATP.RESULTS AND DISCUSSION
OMA1 Degradation, but Not Activation, Is ATP
Dependent
OMA1 protease activation and degradation is proposed to be a
coupled process that suppresses ATP-independent OMA1 pro-
tease activity following an acute insult (Baker et al., 2014). To
test this prediction, we monitored OMA1 activity and degrada-
tion in mitochondria isolated from SHSY5Y cells. Mitochondria
incubated in the absence of ATP did not show reductions in
OMA1 protein levels (Figure 1A). However, the OMA1 protease
was activated as shown by increased OPA1 processing from a
mixed population of long and short isoforms (t = 0 hr) to only
short isoforms (t = 6 hr), which is a process dependent on
OMA1 (Rainbolt et al., 2015). In contrast, the addition of ATP
reduced OMA1 in isolated mitochondria but did not affect
OMA1-dependent OPA1 processing. This suggests that2042 Cell Reports 14, 2041–2049, March 8, 2016 ª2016 The AuthorsOMA1 degradation, but not OMA1 acti-
vation, is dependent on ATP.
OMA1 degradation is also dependent
on ATP in cells. Endogenous OMA1 levels
are rapidly reduced (t1/2 = 1 hr) in SHSY5Y
cells treated with carbonyl cyanide
m-chlorophenylhydrazone (CCCP; Fig-
ures 1B and 1C), a protonophore that
depolarizes mitochondria but does not in-
fluence cellular ATP (Figure S1A). OMA1
is activated under this condition as evi-
denced by the complete processing of
OPA1 from long to short isoforms (Baker
et al., 2014; Zhang et al., 2014). The addi-
tion of the translation inhibitor cyclohexi-mide (CHX) alone does not significantly influence OMA1 levels,
indicating that CCCP-dependent reductions in OMA1 reflect
increased degradation (Figure S1B). CCCP-induced OMA1
degradation is inhibited by co-addition of the glycolysis inhibitor
2-deoxy-D-glucose (2-DG; Figures 1B and 1C), a treatment that
depolarizes mitochondria and reduces cellular ATP (Figure S1A).
OMA1-dependent OPA1 processing was not affected by co-
addition of CCCP and 2-DG, indicating that OMA1was activated
by this treatment. The ATP dependence of membrane-depolari-
zation-induced OMA1 degradation is also evident in SHSY5Y
cells cultured in galactose supplemented media (SHSY5YGAL)
treated with CCCP or the complex III inhibitor antimycin A, two
treatments that depolarize mitochondria and deplete ATP in
SHSY5YGAL cells (Figures S1C and S1D). In both treatments,
we observe OMA1-dependent OPA1 processing but incomplete
OMA1 degradation (Figures 1D, 1E, S1E, and S1F). Interestingly,
these treatments induce the accumulation of a short OMA1
fragment (s-OMA1) previously shown to retain proteolytic activity
(Zhang et al., 2014). Treatment of SHSY5YGAL cells with the ATP
synthase inhibitor oligomycin A, which hyperpolarizes the mito-
chondrial membrane and reduces cellular ATP (Figure S1C),
also modestly induces OPA1 processing but does not induce
complete OMA1 degradation (Figures 1D and 1E). These results
indicate that OMA1 degradation, but not OMA1-mediated OPA1
processing, is dependent on ATP in isolated mitochondria and
living cells.
ATP Availability Dictates YME1L and OMA1 Stability
following Membrane Depolarization
The above results show that membrane depolarization induced
OMA1 degradation is inhibited by ATP depletion. YME1L degra-
dation is induced by cellular insults that depolarize mitochondria
and deplete ATP with a t1/2 of 3 hr (Rainbolt et al., 2015). This
suggests that the stabilities of these two proteases are differen-
tially sensitive to insults that depolarize mitochondria in a pro-
cess dictated by ATP availability. Consistent with this prediction,
YME1L and OMA1 are differentially degraded in isolated mito-
chondria incubated in the absence or presence of ATP, respec-
tively (Figure 1A). The addition of CCCP or antimycin A to
SHSY5YGAL cells also induces YME1L degradation, while only
modestly affecting OMA1 (Figures 1D, 1E, S1E, and S1F). Treat-
ment of SHSY5YGAL cells with oligomycin A alone does not
induce YME1L degradation, reflecting the dependence of this
process on membrane depolarization (Figures 1D and 1E).
YME1L and OMA1 are also differentially degraded in SHSY5Y
cells cultured in glucose-supplemented media and treated with
CCCP ± 2-DG (Figures 1F and S1G). Importantly, OMA1 is acti-
vated under all these conditions, as evident by efficient OPA1
processing. Oxidative insults that deplete ATP and damage the
mitochondrial membrane such as H2O2 also induce degradation
of YME1L, but not activated OMA1 (Rainbolt et al., 2015). Simi-
larly, YME1L is destabilized, while OMA1 remains stable, in
mice subjected to hypoxic-ischemic (HI) injury, a pathologic con-
dition that depletes cellular ATP and induces mitochondrial
dysfunction (Baburamani et al., 2015).
These results indicate that YME1L and OMA1 are differentially
degraded in response to cellular insults that depolarize
mitochondria through a mechanism dictated by ATP availability
(Figure 1G). In the presence of ATP, membrane depolarization
promotes the degradation of activated OMA1. Alternatively, in
the absence of ATP, membrane depolarization stabilizes acti-
vated OMA1 and promotes YME1L degradation.
Membrane-Depolarization-Induced Degradation of
Activated OMA1 Requires YME1L
CCCP-induced OMA1 degradation is predicted to occur through
an autocatalytic mechanism (Baker et al., 2014; Zhang et al.,
2014). We tested this prediction in isolated mitochondria.
ATP-dependent OMA1 degradation in isolated mitochondria is
inhibited by the addition of the zinc chelator o-phenanthroline
(o-phe) (Figure 2A), an inhibitor of zinc metalloproteases such
as OMA1 and YME1L. The inhibition of OMA1 activity by o-phe
is shown by the impaired OPA1 processing. The addition of the
non-hydrolyzable ATP analog AMP-PNP similarly inhibited
degradation of OMA1 but did not influence OMA1-dependentCeOPA1 processing. This indicates that the OMA1 protease is
active, but no autocatalytic degradation is observed. These re-
sults suggest that activated OMA1 is degraded in response to
membrane depolarization through a mechanism involving an
ATP-dependent zinc metalloprotease. One mitochondrial prote-
ase that fits this profile is YME1L. Stress-induced YME1L degra-
dation involves active OMA1 (Rainbolt et al., 2015). Thus, we
evaluated whether OMA1 degradation involves YME1L.
Depletion of YME1L in SHSY5Y cells increases basal OMA1
levels (Figure S2A) and inhibits CCCP-induced OMA1 degrada-
tion (Figures 2B and 2C). OMA1-dependent OPA1 processing
is not affected in YME1L-depleted SHSY5Y cells treated with
CCCP. Identical results were observed in SHSY5Y cells express-
ing an alternative YME1L small hairpin RNA (shRNA) and in
YME1L-depleted HEK293T cells (Figures S2B and S2C). ATP-
dependent OMA1 degradation was also attenuated in mitochon-
dria isolated from YME1L-depleted SHSY5Y cells (Figure S2D).
The expression of RNAi-resistant wild-type YME1L (YME1LWT)
partially rescued the CCCP-induced OMA1 degradation in
YME1L-depleted cells (Figures S2E and S2F). The incomplete
rescueofOMA1degradation in thesecells likely reflects the lower
levels of exogenous YME1L as compared to controls. Overex-
pressing the ATPase deficient E382Q Walker B YME1L mutant
(YME1LWB) or the protease inactive E543Q YME1L mutant
(YME1LPI) showed no rescue of OMA1 degradation in YME1L-
depleted cells (Figures S2E and S2F). These results indicate
that membrane-depolarization induced OMA1 degradation re-
quires YME1L. Interestingly, membrane depolarization appears
to be required for OMA1 degradation, as no significant OMA1
degradation is observed in CHX-treated cells in the absence of
CCCP (Figure S1B). This indicates that YME1L preferentially de-
grades activated OMA1 following membrane depolarization.
Our results suggest that YME1L is involved in the degradation,
but not activation, of OMA1. We further tested this prediction us-
ing an overexpressed C-terminal hemagglutinin (HA)-tagged
OMA1. OMA1 activation can be followed bymonitoring the auto-
catalytic processing of C-terminal tags on OMA1 (Baker et al.,
2014; Zhang et al., 2014). This is evident, as overexpression of
a catalytically inactive E328Q OMA1HA slows the loss of HA-
tagged protein in SHSY5Y cells treated with CCCP and
SHSY5YGAL cells treated with antimycin A (Figures 2D and 2E).
The reduced rate of E328Q OMA1HA loss observed in these cells
likely reflects processing of the C-terminal HA tag in trans by the
endogenous OMA1 also present in these cells. YME1L depletion
does not influence the autocatalytic processing of the C-terminal
HA tag on overexpressed wild-type OMA1HA in CCCP-treated
cells (Figure 2F). This indicates that YME1L is not required for
OMA1 activation.
The above results suggest amodel wherebymembrane-depo-
larization induced OMA1 degradation proceeds through a two-
step mechanism (Figure 2G). First, membrane depolarization
activates the OMA1 protease, allowing rapid processing of
OMA1 substrates such as OPA1. This activation likely involves
autocatalytic processing of the OMA1 protease, explaining pre-
vious results showing a dependence of OMA1 degradation on
OMA1 protease activity (Baker et al., 2014; Zhang et al., 2014).
Second, activated OMA1 is degraded through a mechanism
involving ATP-dependent YME1L activity.ll Reports 14, 2041–2049, March 8, 2016 ª2016 The Authors 2043
Figure 2. OMA1 Degradation Requires ATP-
Dependent YME1L Activity
(A) Immunoblot of mitochondria isolated from
SHSY5Y cells incubated with ATP (5 mM), AMP-PNP
(5 mM) and/or o-phenanthroline (o-phe; 1 mM), as
indicated at 37C for 6 hr.
(B) Immunoblot of lysates prepared from SHSY5Y
cells expressing non-silencing or YME1L shRNA
treated with CCCP (25 mM) for the indicated time.
(C) Quantification of normalized OMA1 protein levels
from immunoblots as shown in Figure 2B. Data were
normalized to t = 0 hr for each shRNA. Error bars
show SEM for n = 5. **p < 0.01.
(D) Immunoblot of lysates prepared from SHSY5Y
cells transfected with wild-type OMA1HA or the
E328Q OMA1HA treated with CCCP (25 mM) for the
indicated time.
(E) Immunoblot of lysates prepared from SHSY5Y
cells cultured in galactose-supplemented media
expressing wild-type OMA1HA or E328Q OMA1HA
treated with antimycin A (100 nM) for the indicated
time.
(F) Immunoblot of lysates prepared from SHSY5Y
cells expressing non-silencing or YME1L shRNA,
transfected with OMA1HA and treated with CCCP
(25 mM) for the indicated time.
(G) Illustration showing the proposed two-step
mechanism of stress-induced OMA1 activation and
degradation. Membrane depolarization activates the
OMA1 protease, allowing rapid processing of OMA1
substrates such as OPA1. Active OMA1 is then
degraded by the ATP-dependent activity of YME1L
suppressing OMA1 proteolytic activity.ATP Depletion Slows the Recovery of Tubular
Mitochondria following Membrane Depolarization
YME1L and OMA1 coordinate to regulate mitochondrial
morphology through their differential processing of the dyna-
min-like GTPase OPA1 (Anand et al., 2014). OPA1 can be ex-
pressed from eight distinct mRNA transcripts that contain a
single OMA1 cleavage site or both OMA1 and YME1L cleavage
sites (Ishihara et al., 2006; Song et al., 2007). YME1L and
OMA1 process OPA1 to yield a balance of 5 OPA1 isoforms:
the long, uncleaved OPA1 isoforms a and b and the short,
cleaved OPA1 isoforms c, d, and e (Figure 3A). YME1L constitu-
tively cleaves longOPA1 to create the d isoform,which promotes
the maintenance of tubular mitochondrial morphology (Mishra
et al., 2014). Alternatively, stress-activated OMA1 processes all
long OPA1 isoforms to the short c and e isoforms that promote
mitochondrial fragmentation (Quiro´s et al., 2012). This indicates
that differential stress sensitivities of YME1L and OMA1 could in-2044 Cell Reports 14, 2041–2049, March 8, 2016 ª2016 The Authorsfluence the distribution of OPA1 isoforms
and mitochondrial morphology following
acute insults.
We tested this prediction by monitor-
ing the distribution of OPA1 isoforms
and mitochondrial morphology in cells
following a pretreatment with CCCP ±
2-DG. This pretreatment will induce alter-
ations in activated OMA1 and YME1Lthrough their differential degradation. Both treatments resulted
in complete OMA1-dependent processing of long OPA1 iso-
forms to the c and e isoforms in SHSY5Y cells (Figures 3A
and 3B; t = 0 hr recovery). The fraction of the YME1L-depen-
dent OPA1 isoform d was not affected by either pretreatment.
The loss of long OPA1 isoforms and the accumulation of the
OMA1-dependent c and e isoforms should promote mitochon-
drial fragmentation. As expected, mouse embryonic fibroblast
(MEF) cells stably expressing a mitochondrial-targeted GFP
(mtGFP) pretreated with CCCP or CCCP + 2-DG show identical
levels of mitochondrial fragmentation (Figures 3C and 3D;
t = 0 hr recovery).
In contrast, the relative accumulation of OPA1 isoforms
following a 6-hr recovery from acute pretreatment with
CCCP ± 2-DG show differences. Pretreatment with CCCP +
2-DG decreased the recovery of the long OPA1 isoforms, rela-
tive to pretreatment with CCCP alone (Figures 3A and 3B).
Figure 3. ATPDepletion Slows the Recovery
of Tubular Mitochondrial Morphology
following Membrane-Depolarization-Indu-
ced Fragmentation
(A) Representative immunoblot of lysates prepared
from SHSY5Y cells pretreated with 2-deoxy-D-
glucose (2-DG; 10 mM) and/or CCCP (25 mM) for
6 hr, washed, and recovered for the indicated
times. An untreated control (U) is also shown. The
experimental protocol is shown above.
(B) Quantification of OPA1 isoforms from immu-
noblots as shown in Figure 3A. Error bars depict
SEM for n = 4. *p < 0.05.
(C) Representative images of MEFs stably ex-
pressing mtGFP treated with 2-DG (10 mM) and/or
CCCP (25 mM) as indicated for 2 hr, washed, and
recovered for the indicated times. Scale bar in-
dicates 5 mm. Red asterisks mark the center of the
expanded region shown.
(D) Quantification of mitochondria morphology in
cells (n R 40 cells per condition) from images as
depicted in Figure 3C. Error bars depict SEM from
n = 3 biologic replicates.Moreover, the relative recovery of OMA1-dependent OPA1 iso-
forms c and e are increased following pretreatment with
CCCP + 2-DG. The decreased levels of long OPA1 isoforms
and the increased levels of the c and e OPA1 isoforms
observed during the recovery from a CCCP + 2-DG pretreat-
ment should impair the restoration of tubular mitochondrial
morphology following stress-induced fragmentation. Consis-
tent with this prediction, we observe reduced levels of tubular
mitochondria and higher levels of fragmented mitochondria in
MEF cells stably expressing mtGFP pretreated with CCCP +
2-DG and allowed to recover for 2, 4, or 6 hr when compared
to the same time course of recovery following pretreatment
with CCCP alone (Figures 3C and 3D). This suggests that the
recovery of tubular mitochondrial morphology following an
acute insult that depolarizes mitochondria and depletes ATP
is delayed through a mechanism that could involve alterations
in OMA1- and YME1L-dependent OPA1 processing.Cell Reports 14, 2041–204The Differential Stress Sensitivity
of YME1L and OMA1 Alters OPA1
Processing during Recovery from
Acute Membrane Depolarization
Many factors could contribute to the
altered distribution of OPA1 isoforms
following acute insults that depolarize
mitochondria and deplete ATP. While
mitochondria membrane polarity is
rapidly restored during recovery from pre-
treatment with CCCP or CCCP + 2-DG
(Figure S3A), the recovery of ATP levels
are modestly delayed in SHSY5Y cells
pretreated with CCCP + 2-DG (Fig-
ure S3B). This delay could influence
OPA1 synthesis and reduce the popula-
tion of long isoforms imported into mito-
chondria during recovery from acuteinsult. [35S]-Metabolic labeling confirmed that pretreating cells
with CCCP + 2-DG reduced the population of newly synthesized
OPA1 following a 6-hr recovery by 40% (Figures 4A and 4B).
CCCP pretreatment also reduced recovery of newly synthesized
OPA1 by 20%. These reductions in newly synthesized OPA1 do
not reflect a global reduction in protein synthesis, as the recovery
of total [35S]-labeled proteins is not significantly affected by
either treatment (Figure S3C). This indicates that the reduction
in OPA1 synthesis involves other factors such as altered OPA1
transcription or impaired OPA1 import into mitochondria.
The distribution of short OPA1 isoforms could also be influ-
enced by the differential degradation of YME1L and active
OMA1 induced by the CCCP ± 2-DG pretreatment. The contribu-
tions of YME1L or OMA1 degradation on OPA1 processing and
the recovery of tubular mitochondrial morphology cannot be as-
certained using genetic approaches. YME1L depletion inhibits
processing of OPA1 to the short d isoform and induces9, March 8, 2016 ª2016 The Authors 2045
Figure 4. OPA1 Processing Is Altered during Recovery from Membrane Depolarization and ATP Depletion
(A) Representative autoradiogram of newly synthesized [35S]-OPA1 immunopurified from SHSY5Y cells pretreated for 6 hr with 2-deoxy-D-glucose (2-DG;
10 mM) and/or CCCP (25 mM) as indicated. The labeling protocol is shown above. Arrows identify the different OPA1 isoforms.
(B) Quantification of total newly synthesized [35S]-OPA1 from autoradiograms as shown in Figure 4A. Error bars show SEM for n = 4. *p < 0.05.
(C) Quantification of fraction OPA1 isoform d (produced by YME1L activity) from autoradiograms as shown in Figure 4A. Error bars show SEM for n = 4. *p < 0.05.
(D) Quantification of fraction OPA1 isoform c (produced by OMA1 activity) from autoradiograms as shown in Figure 4A. Error bars show SEM for n = 4. *p < 0.05.
(E) Representative immunoblot of lysates from SHSY5Y cells pretreated with 2-DG (10mM) and/or CCCP (25 mM) for 6 hr and allowed to recover for the indicated
time. The experimental protocol used for this experiment is analogous to that shown in Figure 3A.
(F) Quantification of normalized full-length and total (full-length OMA1 + s-OMA1) OMA1 protein levels from immunoblots as shown in Figure 4E. The amount of
s-OMA1 is reflected by the difference in full-length and total OMA1 as depicted. Error bars show SEM for n = 4. *p < 0.05.mitochondrial fragmentation in the absence of stress (Anand
et al., 2014; Stiburek et al., 2012). Alternatively, OMA1 depletion
inhibits membrane-depolarization induced OPA1 processing
and mitochondrial fragmentation (Anand et al., 2014; Quiro´s
et al., 2012; Zhang et al., 2014). However, the impact of stress-
induced YME1L or OMA1 degradation on OPA1 processing dur-2046 Cell Reports 14, 2041–2049, March 8, 2016 ª2016 The Authorsing recovery from an acute insult can be quantified using the
assay shown in Figure 4A. YME1L activity can be quantified by
monitoring the fraction of [35S]-labeledOPA1 isoform d (a YME1L
product) following the 6-hr recovery. Alternatively, OMA1 activity
can be quantified by monitoring the fraction of [35S]-labeled
OPA1 isoform c (an OMA1 product) following a 6-hr recovery.
We were unable to quantify OMA1-dependent formation of
isoform e due to low signal for this particular isoform and interfer-
ence from a non-specific background band.
Using this approach, we found that the differential degradation
of YME1L or OMA1 influences proteolytic processing of newly
synthesized OPA1. The fraction of YME1L-dependent OPA1 iso-
form d decreases 50% following CCCP + 2-DG pretreatment
when compared with recovery from CCCP pretreatment alone
(Figures 4A and 4C). This is consistent with the YME1L degrada-
tion observed following this treatment (Figure 1F) (Rainbolt et al.,
2015). Conversely, the fraction of the OMA1-dependent OPA1
isoform c increases 2-fold following pretreatment with CCCP +
2-DG (Figures 4A and 4D). This is consistent with the stabilization
of activated OMA1 under these conditions (Figure 1F). Surpris-
ingly, the relative fraction of the newly synthesized long OPA1
isoforms a and b were not significantly affected following either
pretreatment (Figures S3D and S3E). This indicates that the total
amount of newly synthesized OPA1 processed by either YME1L
orOMA1 is not influenced by the degradation of these proteases.
However, our results indicate that the differential degradation of
these proteases dictates the processing of OPA1 to the pro-
fusion isoform d or the pro-fragmentation isoform c.
Surprisingly, the levels of OMA1-dependent OPA1 processing
observed following pretreatment with CCCP + 2-DG are less
than that observed when CCCP is added to [35S]-labeled cells
30 min prior to harvest (Figures 4A and 4D, CCCP control).
This could reflect the degradation of OMA1 during the recovery
from CCCP + 2-DG afforded by the small amount of remaining
YME1L. Consistent with this prediction, OMA1 levels decrease
60% during the 6 hr recovery from CCCP + 2-DG pretreatment
(Figures 4E and 4F). This decrease appears to result from the
loss of the s-OMA1 cleavage product, as opposed to full-length
OMA1, which is consistent with the lower stability of s-OMA1
(Zhang et al., 2014). OMA1 and YME1L protein levels are both
restored to basal levels following an 18-hr recovery from acute
CCCP + 2-DG insult indicating a return to homeostasis (Figures
4E and 4F). OMA1 and YME1L protein levels also return to
normal levels in vivo following recovery from acute HI injury
(Baburamani et al., 2015). Apart from OMA1 degradation, other
factors could also influence OMA1-dependent OPA1 processing
during recovery from CCCP + 2-DG pretreatment, such as re-
ductions in OMA1 protease activity afforded by restoration of
the membrane potential, slowed OPA1 biosynthesis (Frezza
et al., 2006; Patten et al., 2014), or posttranslational modifica-
tions of OMA1 and/or OPA1 (Samant et al., 2014).
The results shown in Figure 4 indicate that the differential
stress-induced degradation of YME1L and OMA1 influences
OPA1 proteolytic processing during recovery from acute stress.
This suggests that the differential degradation of these prote-
ases alters mitochondrial inner membrane proteolytic activity
and can affect aspects of mitochondrial biology such as the
regulation of mitochondrial morphology.
Concluding Remarks
Here, we show that YME1L and OMA1 are reciprocally degraded
in response to insults that depolarize mitochondria in a process
dictated by cellular energetic status. This likely reflects conforma-
tional alterations induced by reduced nucleotide levels and/orCemembrane depolarization that render YME1L or OMA1 suscepti-
ble to degradation (Baker et al., 2014; Rainbolt et al., 2015; Zhang
et al., 2014). Thedifferential degradationof YME1LandOMA1can
influence aspects of mitochondrial biology such as recovery of
tubular mitochondrial morphology following acute insults. This
regulationofmitochondrialmorphology canprofoundly altermito-
chondrial function. Tubular mitochondria are associated with
enhanced ETC activity, protection frommitophagy, and desensi-
tization to apoptotic insult (Cribbs andStrack, 2007; Gomes et al.,
2011; Rambold et al., 2011; Tondera et al., 2009). Alternatively,
fragmented mitochondria have reduced ETC activity, are more
susceptible to mitophagy, and are associated with apoptosis
(Landes and Martinou, 2011; Twig et al., 2008; Westermann,
2012). Thus, the ability to influence mitochondrial morphology
through thedifferential stress sensitivity ofOMA1andYME1Lpro-
vides a mechanism for cells to adjust mitochondrial function to
distinct types of stress. The differential, reciprocal degradation
of YME1L and OMA1 can also influence other aspects of
mitochondrial function regulated by these proteases including
mitochondrial protein import, degradationof oxidatively damaged
proteins, and BAX/BAK-induced cytochrome c release (Jiang
et al., 2014; Rainbolt et al., 2013, 2015; Stiburek et al., 2012).
Imbalances in YME1L and OMA1 activity afforded by their dif-
ferential degradation could also contribute to mitochondrial
dysfunction observed in human diseases. For example, in vivo
models of neonatal HI injury that depolarize mitochondria and
deplete cellular ATP show increases in OPA1 processing and al-
terations in mitochondria morphology (Baburamani et al., 2015).
Our results would suggest that these effects could be attributed
to imbalances in the stress-dependent regulation of YME1L and
OMA1 resulting in YME1L degradation and the stabilization of
activated OMA1. Consistent with this prediction, YME1L levels
are reduced andOMA1 is stabilized in these HI models, suggest-
ing that imbalances in the reciprocal degradation of these
proteases contribute to the observed mitochondria dysfunction
(Baburamani et al., 2015). OMA1 deletion also rescues mito-
chondrial defects induced by YME1L depletion both in vitro
and in vivo, further suggesting that imbalances in the reciprocal
regulation of these proteases disrupts mitochondrial biology
(Anand et al., 2014; Wai et al., 2015).
Mitochondrial depolarization and metabolic stress are impli-
cated in the onset and pathology of many diseases including
neurodegenerative disorders and cardiovascular disease (Nun-
nari and Suomalainen, 2012; Quiro´s et al., 2015; Rugarli and
Langer, 2012). Chronically such conditions would favor the
loss of YME1L and promote the stabilization of active OMA1.
This could induce pathologic changes in mitochondrial function
associated with these diseases. Thus, our identification of the
reciprocal degradation of YME1L and OMA1 reveals a regulatory
mechanism to adapt mitochondria function to specific insults
and whose imbalance could contribute to the pathologic mito-
chondria dysfunction observed in diverse diseases.EXPERIMENTAL PROCEDURES
Cellular Lysate Preparation and Immunoblotting
Whole-cell lysates were prepared in lysis buffer (20 mM HEPES [pH 7.4],
100 mM NaCl, 1 mM EDTA, and 1% Triton X-100 supplemented withll Reports 14, 2041–2049, March 8, 2016 ª2016 The Authors 2047
EDTA-free protease inhibitors [Roche]). Protein concentration in lysates was
normalized using the Bio-Rad protein assay. Lysates were separated by
electrophoresis on Tris-glycine gels and transferred onto nitrocellulose mem-
branes (Bio-Rad) for immunoblotting. Membranes were blocked and then
incubated with the indicated primary antibodies and visualized following in-
cubation with appropriate IR-Dye conjugated secondary antibodies using
the Odyssey Infrared Imaging System (LI-COR Biosciences). Quantification
was carried out with LI-COR Image Studio software.
[35S] Metabolic Labeling and Immunoprecipitation
Cells were metabolically labeled with 110 mCi/ml EasyTag EXPRESS35S Pro-
tein Labeling Mix (PerkinElmer) in DMEM without cysteine and methionine
(Corning-Cellgro) supplemented with 10% dialyzed fetal bovine serum,
2 mM L-glutamine, 100 U ml1 penicillin, and 100 mg ml1 streptomycin.
After treatment as indicated, cells were washed and recovered in the labeling
media for 6 hr. Following labeling, lysates were prepared in lysis buffer and
denatured with 1% SDS by boiling for 5 min at 100C. Denatured lysates
were diluted 10-fold into RIPA buffer without SDS (50 mM Tris [pH 7.5],
150 mM NaCl, 0.5% sodium deoxycholate, and 1% Triton X-100) and pre-
cleared by incubation with Sepharose 4B beads (Sigma). OPA1 was immu-
noprecipitated with OPA1 antibody (BD Transduction Labs) conjugated to
protein G Sepharose beads (Life Technologies). The beads were washed
four times in RIPA buffer, and labeled OPA1 was eluted by boiling in 63
Laemmli buffer, separated by SDS-PAGE, and imaged by autoradiography
using a Typhoon Trio Imager (GE Healthcare). Densitometry analysis of auto-
radiograms was carried out with Fiji ImageJ software. The fraction of OPA1
isoforms was calculated using the equation: [35S]-labeled OPA1 isoform/total
[35S]-labeled OPA1.
Statistical Analysis
Data are presented as mean ± SEM and were analyzed by Student’s t test to
determine significance.
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